Biao Xu

Title: Biao Xu: Innovator in Multi-Target Peptide Molecules

Introduction

Biao Xu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of peptide research, particularly in the development of multi-target peptide molecules. His work focuses on the intersection of opioid and neuropeptide systems, which has important implications for medical science.

Latest Patents

Biao Xu holds a patent for "Multi-target peptide molecules of opioid and neuropeptide FF receptor, preparation for molecules, and applications thereof." This patent includes nine multi-target polypeptides that are designed to activate various opioid and NPFF system receptors concurrently. The innovative approach involves replacing amino acids based on the opioid peptide biphalin and the NPFF-based chimeric peptide BN-9. This advancement opens new avenues for therapeutic applications.

Career Highlights

Biao Xu is affiliated with Shanghai Tianci Life Science Development Co., Ltd., where he continues to push the boundaries of peptide research. His work has garnered attention for its potential to address complex medical challenges through innovative peptide design.

Collaborations

Biao Xu collaborates with talented colleagues, including Quan Fang and Zilong Wang. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

Biao Xu's contributions to the field of peptide research exemplify the importance of innovation in medical science. His patented work on multi-target peptide molecules represents a significant step forward in understanding and utilizing the opioid and neuropeptide systems.